Submitted by Anonymous (not verified) on 5 October 2023 - 11:24
Human medicines European public assessment report (EPAR): Kimmtrak, tebentafusp, Uveal Neoplasms, Date of authorisation: 01/04/2022, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kimmtrak, tebentafusp, Uveal Neoplasms, Date of authorisation: 01/04/2022, Revision: 1, Status: Authorised